Cutaneous lupus erythematosus: Diagnosis and treatment

Best Practice and Research: Clinical Rheumatology

Volumn 27, Issue 3, 2013, Pages 391-404

  Okon, L G ^a   Werth, V P ^a  

^a Perelman Center for Advanced Medicine   (United States)

Author keywords

Acute cutaneous lupus erythematosus; Chronic cutaneous lupus erythematosus; Cutaneous lupus erythematosus; Diagnosis; Discoid lupus erythematosus; Lupus erythematosus profundus; Lupus erythematosus tumidus; Sub acute cutaneous lupus erythematosus; Systemic lupus erythematosus; Treatment

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BELIMUMAB; CALCINEURIN INHIBITOR; CHLOROQUINE; CLOBETASOL PROPIONATE; CLOFAZIMINE; CORTICOSTEROID; DAPSONE; ECAMSULE; ETRETIN; FLUOCINONIDE; FOLIC ACID; HYDROCORTISONE; HYDROXYCHLOROQUINE; MEPACRINE; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; RITUXIMAB; SALBUTAMOL; STEROID; SUNSCREEN; TACROLIMUS; TITANIUM DIOXIDE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; ZINC OXIDE;

ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS; ACUTE DISEASE; AGRANULOCYTOSIS; ALLERGIC REACTION; APLASTIC ANEMIA; ARTICLE; ASTHMA; ATROPHY; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CARDIOMYOPATHY; CHILBLAIN; CHILBLAIN LUPUS ERYTHEMATOSUS; CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS; CHRONIC DISEASE; CREAM; CRYOTHERAPY; DERMATITIS; DIAGNOSTIC TEST; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CLASSIFICATION; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEADACHE; HEMOLYSIS; HUMAN; HYPERPIGMENTATION; INSOMNIA; INTERMITTENT SKIN LUPUS ERYTHEMATOSUS; INTERSTITIAL PNEUMONIA; LICHENOID ERUPTION; LIVER TOXICITY; LOW LEVEL LASER THERAPY; LUPUS ERYTHEMATOSUS PROFUNDUS; LUPUS ERYTHEMATOSUS TUMIDUS; METHEMOGLOBINEMIA; MYOPATHY; NEPHROTOXICITY; PRIORITY JOURNAL; PSYCHOSIS; RECOMMENDED DRUG DOSE; RETINOPATHY; SCLERA DISEASE; SKIN ABRASION; SKIN DISCOLORATION; SKIN LUPUS ERYTHEMATOSUS; TELANGIECTASIA; URTICARIA; XEROSIS;

EID: 85027948004     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2013.07.008     Document Type: Review

References (83)

1. B. Tebbe, and C.E. Orphanos Epidemiology and socioeconomic impact of skin disease in lupus erythematosus Lupus 6 1997 96 104
2. C. Biazar, J. Sigges, N. Patsinakidis, V. Ruland, S. Amler, and G. Bonsmann Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Autoimmunity Reviews 12 2013 444 454
3. J. Albrecht, J.A. Berlin, I.M. Braverman, J.P. Callen, M.I. Costner, and J. Dutz Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus Lupus 13 2004 839 849
4. C.M. Gronhagen, C.M. Fored, F. Granath, and F. Nyberg Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden British Journal of Dermatology 164 6 2011 1335 1341
5. I.T. Wieczorek, K. Propert, J. Okawa, and V.P. Werth Progression from cutaneous to systemic lupus erythematosus by ACR criteria usually occurs with mild disease and few systemic symptoms Journal of Investigative Dermatology (Abstract) 132 2012 S45
6. M. Petri, A.M. Orbai, G.S. Alarcon, C. Gordon, J.T. Merrill, and P.R. Fortin Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus Arthritis and Rheumatism 64 8 2012 2677 2686
7. J.N. Gilliam, and R.D. Sontheimer Distinctive cutaneous subsets in the spectrum of lupus erythematosus Journal of American Academy of Dermatology 4 1981 471 475
8. A. Kuhn, and T. Ruzicka Classification of cutaneous lupus erythematosus A. Kuhn, P. Lehmann, T. Ruzicka, Cutaneous lupus erythematosus 2004 Springer Verlag Berlin 53 58
9. P.P. Ng, S.H. Tan, E.T. Koh, and T. Tan Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore Australian Journal of Dermatology 41 2000 229 233
10. P. Fabbri, C. Cardinali, B. Giomi, and M. Caproni Cutaneous lupus erythematosus: diagnosis and management American Journal of Clinical Dermatology 4 7 2003 449 465
11. H.W. Walling, and R.D. Sontheimer Cutaneous lupus erythematosus: issues in diagnosis and treatment American Journal of Clinical Dermatology 10 6 2009 365 381
12. L.A. Lee, and V.P. Werth Lupus erythematosus J.L. Bolognia, Dermatology 3rd ed. 2012 Elsevier Ltd London 601
13. N. Rothfield, R.D. Sontheimer, and M. Bernstein Lupus erythematosus: systemic and cutaneous manifestations Clinics in Dermatology 24 2006 348 362
14. P. Patel, and V.P. Werth Cutaneous lupus erythematosus: a review Clinics in Dermatology 20 2002 3 385
15. N.R. Rowell, J.S. Beck, and J.R. Anderson Lupus erythematosus and erythema multiforme-like lesions Archives of Dermatology 88 1963 176 180
16. B. Tebbe, U. Mansmann, U. Wollina, P. Auer-Grumbach, A. Licht-Mbalyohere, and M. Arensmeier Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients Acta Dermato Venereologica 77 4 1997 305 308
17. J.P. Callen, and J. Klein Subacute cutaneous lupus erythematosus: clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients Arthritis and Rheumatism 31 1988 1007 1013
18. A. Parodi, M. Caproni, C. Cardinali, E. Bernacchi, A. Fuligni, and G. De Panfilis Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus: a review by the Italian group of immunodermatology Dermatology 200 2000 6 10
19. S. Moghadam-Kia, K. Chilek, E. Gaines, M. Costner, M.E. Rose, and J. Okawa Cross-sectional analysis of a collaborative web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients Archives of Dermatology 145 3 2009 255 260
20. R.D. Sontheimer, J.R. Thomas, and J.N. Gilliam Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset Archives of Dermatology 115 12 1979 1409 1415
21. M. Caproni, C. Cardinali, E. Salvatore, and P. Fabbri Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations International Journal of Dermatology 40 2001 59 62
22. A. Kuhn, M. Sticherling, and G. Bonsmann Clinical manifestations of cutaneous lupus erythematosus Journal der Deutschen Dermatologischen Gesellschaft 5 2007 1124 1140
23. M.R. Cohen, and D. Crosby Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus Journal of Rheumatology 21 1994 1665 1669
24. R.D. Sontheimer Subacute cutaneous lupus erythematosus Clinics in Dermatology 3 3 1985 58 68
25. R.D. Sontheimer, P.J. Maddison, M. Reichlin, R.E. Jordon, P. Stastny, and J.N. Gilliam Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus Annals of Internal Medicine 97 1982 664 671
26. C.M. Gronhagen, C.M. Fored, M. Linder, F. Granath, and F. Nyberg Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden British Journal of Dermatology 167 2 2012 296 305
27. C. Nieboer, Z. Tak-Diamand, and H.E. Van Leeuwen-Wallau Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus British Journal of Dermatology 118 1988 725 729
28. A.N. Crowson, and C. Magro The cutaneous pathology of lupus erythematosus: a review Journal of Cutaneous Pathology 28 2001 1 23
29. B.F. Chong, J. Song, and N.J. Olsen Determining risk factors for developing systemic lupus erythematosus in patients with DLE British Journal of Dermatology 166 1 2012 29 35
30. M.A. Vera-Recabarren, M. Garcia-Carrasco, M. Ramos-Casals, and C. Herrero Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients British Journal of Dermatology 162 2010 91 101
31. W.R. Caruso, M.L. Stewart, V.K. Nanda, and F.P. Quismorio Jr. Squamous cell carcinoma of the skin in black patients with discoid lupus erythematosus Journal of Rheumatology 14 1987 156 159
32. D.P. McCauliffe Cutaneous lupus erythematosus Seminars in Cutaneous Medicine and Surgery 20 2001 14 26
33. C.M. Magro, A.N. Crowson, and T.J. Harrist Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue disease American Journal of Dermatopathology 19 1997 446 455
34. C.M. Hedrich, B. Fiebig, F.H. Hauck, S. Sallmann, G. Hahn, and C. Pfeiffer Chilblain lupus erythematosus: a review of the literature Clinics in Rheumatology 27 8 2008 949 954
35. A. Kuhn, D. Richter-Hintz, C. Oslislo, T. Ruzicka, M. Megahed, and P. Lehmann Lupus erythematosus tumidus: a neglected subset of cutaneous lupus erythematosus: report of 40 cases Archives of Dermatology 136 2000 1033 1041
36. M.H. Liang, S.A. Socher, W.N. Roberts, and J.M. Esdaile Measurement of systemic lupus erythematosus activity in clinical research Arthritis and Rheumatism 31 7 1988 817 825
37. A. Parodi, C. Massone, M. Cacciapuoti, M.G. Aragone, P. Bondavalli, and G. Cattarini Measuring the activity of the disease in patients with cutaneous lupus erythematosus British Journal of Dermatology 142 2000 457
38. J. Albrecht, L. Taylor, J.A. Berlin, S. Dulay, G. Ang, and S. Fakharzadeh The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus Journal of Investigative Dermatology 125 2005 889 894
39. M.S. Krathen, J. Dunham, E. Gaines, J. Junkins-Hopkins, E. Kim, and S.L. Kolasinski The cutaneous lupus erythematosus disease activity and severity index: expansion for rheumatology and dermatology Arthritis and Rheumatism 59 3 2008 Mar 15 338 344
40. M. Jolly, N. Kazmi, R.A. Mikolaitis, W. Sequeira, and J.A. Block Validation of the cutaneous lupus disease area and severity index (CLASI) using physician- and patient-assessed health outcome measures Journal of American Academy of Dermatology 68 4 2012 618 623
41. A.Y. Chang, E. Ghazi, J. Okawa, and V.P. Werth Quality of life differences between responders and non-responders in the treatment of cutaneous lupus erythematosus JAMA Dermatology 149 1 2013 104 106
42. R. Klein, S. Moghadam-Kia, J. LoMonico, J. Okawa, C. Coley, and L. Taylor Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus Archives of Dermatology 147 2 2011 203 208
43. I. Braunstein, R. Klein, J. Okawa, and V.P. Werth The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score British Journal of Dermatology 166 5 2012 971 975
44. A.S. Nabatian, M.M. Bashir, M. Wysocka, M. Sharma, and V.P. Werth Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients Arthritis Research and Therapy 14 1 2012 R1
45. R. Vasquez, D. Wang, Q.P. Tran, B. Adams-Huet, M.M. Chren, and M.I. Costner A multi-center, cross-sectional study on quality of life in cutaneous lupus erythematosus British Journal of Dermatology 168 2012 145 153
46. G.G. Marin, M.H. Cardiel, H. Cornejo, and M.E. Viveros Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases Journal of Clinical Rheumatology 15 70 2009 325 329
47. K.M. David-Bajar, S.D. Bennion, J.D. DeSpain, L.E. Golitz, and L.A. Lee Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus Journal of Investigative Dermatology 99 1992 251 257
48. A. Kuhn, A. Wozniacka, J.C. Szepietowski, R. Glaser, P. Lehmann, and M. Haust Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol Journal of Investigative Dermatology 131 8 2011 1622 1630
49. V. Ruland, M. Haust, R.M. Stilling, D. Metze, S. Amler, and T. Ruzicka Updated analysis of standardized photoprovocation in patients with cutaneous lupus erythematosus Arthritis Care and Research 65 5 2013 767 776
50. A. Kuhn, M. Sonntag, D. Richter-Hintz, C. Oslislo, M. Megahed, and T. Ruzicka Phototesting in lupus erythematosus: a 15-year experience Journal of American Academy of Dermatology 45 1 2001 86 95
51. A. Kuhn, K. Gensch, M. Haust, A. Meuth, F. Boyer, and P. Dupuy Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study Journal of American Academy of Dermatology 64 1 2011 37 48
52. R.S. Klein, V.P. Werth, J.C. Dowdy, and R.M. Sayre Analysis of compact fluorescent lights for use by patients with photosensitive conditions Photochemistry and Photobiology 85 4 2009 1004 1010
53. R.M. Sayre, J.C. Dowdy, and M. Poh-Fitzpatrick Dermatological risk of indoor Ultraviolet exposure from compact fluorescent light or use by patients with photosensitive conditions Photochemistry and Photobiology 85 4 2009 1004 1010
54. A. Kuhn, V. Ruland, and G. Bonsmann Cutaneous lupus erythematosus: update of therapeutic options: part 1 Journal of American Academy of Dermatology 65 6 2011 e179 e193
55. S. Jessop, D.A. Whitelaw, and F.M. Delamere Drugs for discoid lupus erythematosus Cochrane Database System Review 4 2009 CD002954
56. H.H. Roenigk, J.S. Martin, P. Eichorn, and J.N. Gilliam Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy Cutis 25 1980 281 285
57. A.Y. Chang, and V.P. Werth Treatment of cutaneous lupus Current Rheumatology Reports 13 4 2011 300 307
58. T.Y. Tzung, Y.S. Liu, and H.W. Chang Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study British Journal of Dermatology 156 1 2007 191 192
59. A. Kuhn, K. Gensch, M. Haust, S.W. Schneider, G. Bonsmann, and N. Gaebelein-Wissing Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial American Academy of Dermatology 65 1 2011 54 64
60. D. Thaci, and R. Salgo Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies Clinics in Dermatology 28 2010 52 56
61. G.B. Jemec, S. Ullman, M. Goodfield, A. Bygum, A.B. Olesen, and J. Berth-Hones A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus British Journal of Dermatology 161 6 2009 1365 1370
62. A. Erceg, H.J. Bovenschen, P.C. van der Kerkhof, M.J. de Jong, and M.M. Seyger Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus Journal of American Academy of Dermatology 60 4 2009 626 632
63. T. Ruzicka, C. Sommerburg, G. Goerz, P. Kind, and H. Mensing Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine British Journal of Dermatology 127 1992 513 518
64. E.L. Bezerra, M.J. Vilar, P.B. da Trindade Neto, and E.I. Sato Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus Arthritis and Rheumatism 52 10 2005 3073 3078
65. A.Y. Chang, E.W. Piette, K.P. Foering, R.R. Tenhave, J. Okawa, and V.P. Werth Response to antimalarials in cutaneous lupus erythematosus: a prospective analysis Archives of Dermatology 147 11 2011 1261 1267
66. C. Frances, A. Cosnes, P. Duhaut, N. Zahr, B. Soutou, and S. Ingen-Housz-Oro Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study Archives of Dermatology 148 4 2012 479 484
67. E.W. Piette, K.P. Foering, A.Y. Chang, J. Okawa, T.R. Ten Have, and R. Feng Impact of smoking in cutaneous lupus erythematosus Archives of Dermatology 148 3 2012 317 322
68. N. Ezra, and J. Jorizzo Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus Clinical and Experimental Dermatology 37 4 2012 327 334
69. M.F. Marmor, R.E. Carr, M. Easterbrook, A.A. Farjo, and W.F. Mieler Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology Ophthalmology 109 2002 1377 1382
70. R.R. Winkelmann, G.K. Kim, and J.Q. Del Rosso Treatment of cutaneous lupus erythematosus: review and assessment of treatment benefits based on Oxford centre for evidence-based medicine criteria Journal of Clinical and Aesthetic Dermatology 6 1 2013 27 38
71. A. Kuhn, V. Ruland, and G. Bonsmann Cutaneous lupus erythematosus: update of therapeutic options: part 2 Journal of American Academy of Dermatology 65 6 2011 e195 e213
72. J. Wenzel, S. Brahler, R. Bauer, T. Bieber, and T. Tuting Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients British Journal of Dermatology 153 1 2005 157 162
73. A. Kreuter, N.S. Tomi, S.M. Weiner, M. Huger, P. Altmeyer, and T. Gambichler Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy British Journal of Dermatology 156 6 2007 1321 1327
74. R. Ashinoff, V.P. Werth, and A.G. Franks Jr. Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine Journal of American Academy of Dermatology 19 1988 961 965
75. G.C. Tsokos, S.W. Caughman, and J.H. Klippel Successful treatment of generalized discoid skin lesions with azathioprine: its use in a patient with systemic lupus erythematosus Archives of Dermatology 121 1986 1323 1325
76. S. Shehade Successful treatment of generalized discoid skin lesions with azathioprine Archives of Dermatology 122 1986 276 277
77. S. Manzi, J. Sánchez-Guerrero, and J.T. Merrill Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials Annals of the Rheumatic Diseases 71 11 2012 1833 1838
78. J. Cortes-Hernandez, M. Torres-Salido, J. Castro-Marrero, M. Vilardell-Tarres, and J. Ordi-Ros Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome British Journal of Dermatology 166 3 2012 616 623
79. S. Bastuji-Garin, S. Ochinisky, P. Bouche, R.K. Gherardi, C. Duguet, and Z. Djerradine Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients Journal of Investigative Dermatology 119 5 2002 1020 1026
80. I. Braunstein, N.G. Goodman, M. Rosenbach, J. Okawa, A. Shah, and M. Krathen Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare Journal of American Academy of Dermatology 66 4 2012 571 582
81. J. Cortés-Hernández, G. Avila, M. Vilardell-Tarrés, and J. Ordi-Ros Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus Arthritis Research and Therapy 14 6 2012 R265
82. A. Shah, J. Albrecht, Z. Bonilla-Martinez, J. Okawa, M. Rose, and M. Rosenbach Lenalidomide for the treatment of resistant discoid lupus erythematosus Archives of Dermatology 145 3 2009 303 306
83. A. Kuhn, N. Patsinakidis, and T. Luger Alitretinoin for cutaneous lupus erythematosus Journal of American Academy of Dermatology 67 3 2012 Sep e123 e126